IN THE PAST few years, determination of the serum or plasma activity of predomninantly intracellular enzyme systenms has become a valuable adjunct in the study of disease. Since the original report of LaDue et al.1 many groups have investigated the levels of serum glutamic oxalacetic transaminase activity in a wide variety of conditions. Both myocardiuni and liver contain high concentrations of this enzyme, and clinical experienee has demonstrated the value of repeated determinations of blood transamiliase activity in the diagnosis and evaluation of myocardial infaretion and liver disease. 2 In animals an uncomplicated acute meyocardial infaretion is associated with inereases in serum glutamic oxalacetic transaminase activity that correlate roughly with the amount of infarcted muscle. [3] [4] [5] [6] In the majority of patients sufferilng from an acute myocardial infaretion, the changes in blood enzyme activity resemble those produced in the experimelntal animal; after the first day, the level increases, usually to less than 400 units. and then graduallv falls to normal within a 3or 4-day period.7 Infrequently, however, the blood enzyme activity soars to very high levels followiing an acute myocardial infaretion. In animal experiments, such high levels of enzyme activity have been recorded only in instanees of very large infarets.3 6 Occasional patients have been cited with very high seruiii levels of glutamic oxalacetic transaminase activity prior to death from a myocardial infaretion, and autopsy disclosed central necrosis of the liver.7' 8 It has been postulated that the liver nmay contribute to these unusual levels of blood enzymne activity. 8' 9 There has lnot, however, been ani extensive clinical survey of this problemn.
From the Department of Medicine, The New York
Hospital-Cornell Medical Center, New York, NT. Y. 646 Recently we observed a young man with advanced rheumatic heart disease and tight aortic stenosis who developed progressive hepatic dysfunetion ( fig. 1 ) during his final illness and showed a rise in serum glutamic oxalacetic transaminase activity to 1,912 units (W.D., table 1). At postmnortem examination there was severe acute central nlecrosis of the liver ( fig. 2) . Coincidentally there was a report of a similar patient with a very high transaminase activity in whom a clinical diagnosis of hepatitis had been considered although hepatic central necrosis was demonstrated at autopsy.10 These observations stimulated an extensive review of our experience at The New York Hospital with patients having cardiac disease and high levels of serum glutaimic oxalacetic transaminase activity, and this review formns the basis of the present report.
Materials and Methods
The records were reviewed of every patient who had a serumii glutamic oxalacetic transaminase activity (SGOT) greater than 500 units per milliliter per minute as determined in the Liver Laboratorv of The New York Hospital fromti January 1956 through July 1958. The records of those patients who had primary cardiovascular disease and high levels of enzyvme activity were selected for special study. No patients with clinically evident viral hepatitis, toxic hepatitis, cirrhosis, or biliary tract disease were included.
The recorded clinical informiiation was scrutinized for evidence of heart failure and hypotension. Right heart failure was diagnosed when the venous pressure was elevated and the liver was enlarged and tender. The level of venous pressure was measured by direct saline manometry and referred to the estimated level of the right atrium, or was estimated bv inspection of the neck veins.
Hypotension was diagniosed when the systolic blood pressure was 20 mmn. Hg below the previously recorded levels on 2 or more consecutive bedside determinations. A diagnosis of clinical shock was made when specific comments indicated Circulation, Volume XXI, the presence of severe hypotension, cold wet skin, and peripheral eyanosis, usually accompanied by changes in mentation.
In those cases in which an autopsy had been performed, the sections of the liver and other tissues were carefully reviewed. The microscopic appearance of the hepatic sections was categorized as follows: normal, central congestion, central hepatic cord atrophy, central fibrosis, acute central necrosis. A careful attempt was made to distinguish between chronic or long-standing and acute changes in the hepatic architecture. Central fibrosis or atrophy was interpreted as evidence of chronic change. Central atrophy was diagnosed when the plates or cords of hepatic cells radiating toward the hepatic vein were thin, often not reaching the central vein, without evidence of acute necrosis, and the sinuses were dilated. In evaluation of acute central necrosis the criteria described by Osserman and Ellenbergo" were utilized: eosinophilic staining of the central area sharply contrasting with the basophilic stain of the normal liver cells; nuclear changes including pyknosis, fragmentation, occasional large pale nuclei, and occasional free nuclei; invasion by polymorphonuclear leukocytes; more or less architectural disruption depending on the age of the lesion. Central congestion, though often present, was not considered essential for a diagnosis of acute central necrosis.
Further to evaluate the clinical and autopsy correlations that became apparent among those patients with high transaminase activity, a second series was accumulated from the autopsy files of The New York Hospital. This group will be termed a "Control Series," since it was selected without regard for the level of SGOT activity.
The records of all patients who died primarily from cardiac disease and were autopsied during the 30-month period from January 1956 to Julyl 1958, and who had SGOT activity determined within 30 hours before death, were reviewed. Eighteen patients met these criteria, none of whom had clinical or autopsy evidence of primary hepatic disease, and constitute the "Control Series."
Serum transanminase activity was determined by a modification of the method of Karmen12 and was reported as units per Although the nunmber of patients involved is small, table 1 indicates that the higher the SGOT in patients with cardiac disease, the worse is the prognosis. Five of 7 with SGOT between 500 and 700 unlits survived, whereas 8 of 10 with levels greater than 700 uniits died.
Serum transamlinase activitv usually fell sharply after the peak level and was often nornial within a week ini those patients who survived the initial episode ( fig. 3 ). In W.T., in whom shock persisted for 10 days despite vigorous treatment, the tranisaminiase activity fell from a peak of 6,230 niiits to 200-350 units durinig a 4-day period and remaiiied at that level until death.
The clinical association between the peak seruii transamiiiase activity and the level of blood pressure was striking. In all 17 patielnts, the elevation of SGOT to more than 500 unlits was preceded by a fall in blood pressure pro-dueinig significant hypotelnsion or overt clinical shock (table 1). The duratiotn of the hypotensioni could not alwavs be determnined precisely from the available record, but in those patients from whom adequate data were available hypotension had beeni present for at least 6 hours prior to the SGOT elevation. Sixteeln of the 117 patieiits also had right heart failure of varying severity. The hypotension, heart failure, and very high transamiuiase level oceurred in differen-t settings: as a direct complicatioll of acute myocardial infaretion, in association with severe m-yocardial failure, and secondary to a rapid arrhythmia in a patient with a diseased heart.
Liver-function tests were frequently abnormal when SGOT activity rose to high levels. Serum bilirubins were elevated in 7 of 8 patients in whoin the determination was available. Four patients had excessive inereases in prothrombin time (over 60 When the liver sectiotis xvere (raded act,01ing to thie detlree of cent rla areniteetuiral collapse, loss of hIcpatie-ell outlilles, and atnonint of 1iver cell regen-o-erlation, the apparl cut ag,e of the lesion correlated Ax-itlh thle timlieI frotn peak trnainase actitvit u.1titlda. Patient L.L. wxas unusual in tliat the cvideuee for (central. nero sil IxsN'i thle reg-etiIe1tiotu of the cells arointidth'ecentral veins a-is itidicated by\ larg-e., pale, double nuclei with )ale-stamining cytoplasm. r1'}iis observation. A few selected cases are presented to illustrate the clinieal and pathologic correlations encountered in this group of patients with heart disease and high SGOT activity. 
Comment
High SGOT activity in this patient was associated with a large myocardial infaretion complicated by severe heart failure, complete heart block, and prolonged shock. Autopsy revealed in addition to the myocardial infaretion an extensive central niecrosis of the liver of recent origini. If the sections viewed under the microscope are representative a large proportion of the liver was necrotic. Although there was extensive destruction of heart muscle, leak of enzymes from the necrotic liver cells must have contributed in large part to the very high levels of serum transaminase activity recorded prior to death.
Case 2
A 47-year-old iman, R.L., was admitted to The New York Hospital 6 hours after the onset of severe precordial pain. During the 18 months prior to admission he had occasional attacks of angina pectoris, and his physician had recorded blood pressures of 150 to 170/80 to 110.
On admission he had a blood pressure of 120/90 mm. Hg and a regular pulse of 100 per minute.
There were basal rales, distended neck veins, and Circulation, Volume XXI, May 196o an enlarged, tender liver. The venous pressure was 145 mm. of saline. An electrocardiogram showed a recent transmural anterior myocardial infaretion.
SGOT activity 8 hours after the onset of chest pain was 77 units. Twelve hours after admission his blood pressure fell to 100/70 mm. Hg, without signs of clinical shock, remained low for 24 hours, and then gradually rose to 120/80. SGOT activity 8 hours after the onset of the hypotension had increased to 870 units ( fig. 3 ). The patient improved until the sixteenth day after admission, when he suddenly had a recurrence of his chest pain and died.
Postmortem examination revealed a recent occlusion of the circumflex branch of the left coronary artery with an infaretion of the anterior wall of the left ventricle estimated to be 2 weeks old. A mural thrombus was adherent to the infareted area, and there were several small infarets of the kidneys. Microscopic sections of the liver showed active regeneration of the hepatic cells around the central vein with large, pale, reduplicated nuclei.
Comment
High SGOT activity in this patient occurred after an acute myocardial infarction was complicated by heart failure and hypotension. The serum transaminase activity several hours after the fall in blood pressure was considerably higher than that usually encountered in patients with an uncomplicated myocardial infarction. The regeneration of liver cells around the central vein demonstrated at postmortem examination 2 weeks after the infaretion is interpreted as evidence of an acute but limited hepatic central necrosis that was undergoing repair. The hepatic injury was probably secondary to the fall in blood pressure that occurred shortly after admission and was undoubtedly an important factor in the high level of SGOT activity that occurred at that time. The renal infaretions were quite small and most likely did not contribute significantly to the SGOT elevation. Case was atrial fibrillation at a rate of 90 per minute. He had physical findings of aortic stenosis and insufficiency, mitral stenosis and insufficiency, and tricuspid insufficiency. There were bilateral pleural effusions, rales over both lung fields, an enlarged tender liver, and ankle edema. Shortly after admission SGOT activity was 1,206 units, a blood urea nitrogen was 45 mg. per cent, and a serum bilirubin was 4.9 mg. per cent ( fig. 1 ). Two days later the blood pressure fell and became unobtainable for 32 hours, despite intermittent norepinephrine therapy. The rhythm then reverted spontaneously to normal at a slow rate and the blood pressure was maintained at 110/80 mm. Hg. On the fourth day the serum transaminase activity was 1,912 units, the serum bilirubin was 15.0 mg. per cent, with 9.2 mg. in the direct fraction, and the blood urea nitrogen was 105 mg. per cent. Five days after admission a venous blood ammonia was 190 gamma per cent (normal <100). He died oln the thirteenth hospital day.
At autopsy the heart weighed 700 Gmn. There was tight aortic stenosis, imioderate mitral stenosis and insufficieney, and a widely dilated tricuspid valve. Both ventricles were hypertrophied. There was no evidence of necrosis in the myocardium or Seven patients had normal SGOT activity prior to death (table 3). In none was central necrosis of the liver demonstrated at autopsy, and none had hypotension or shock prior to death. Four of these patients died during a bout of right heart failure, and in 3 the failure was severe. Noteworthy is case 3, who died from cor pulmonale associated with kyphoscoliosis, severe right heart failure (veiious pressure greater than 300 mm. saline) anld deep evanosis. Despite these abniormalities the blood pressure was mnaintained and SGOT activity was normal 16 hours before Circulation, Volume XXI, May 1960 death. At postmortem examiniationi the liver showed central congestion without necrosis ( fig. 6 ). In case 4, SGOT activity was normal 4 hours prior to death from advanced rheumatic heart disease with severe right and left heart failure without hypotension. Autopsy revealed a severely congested liver without evidenee of acute necrosis ( fig. 7 ). From this small group of patients it may be concluded that venous hypertension alone is probably not associated with either acute central necrosis of the liver or elevation of the SGOT activity.
The data from the 11 patients with elevated SGOT activity (table 3) provide further confirmation of the relationships noted previously in the group of patients with very high serum enzyme activity. All 5 of the patients with hepatic central necrosis had hypotension for more than 6 hours prior to death. In all but 2 of the patients with elevated SGOT ae-653 r _ Discussion This study has demonstrated that a group of patients suffering from heart disease with very high levels of SGOT activity had several factors in common: right heart failure, hypotension or shock preceding the SGOT elevation, and, in those autopsied, central necrosis of the liver. All 8 patients who came to autopsy had acute central necrosis of the liver, which appeared to be related in time to the elevated serum transaminase activity. Clinical and laboratory data from the 9 patients who were not autopsied were essentially similar to those from the autopsied group, and it is reasonable to assume that they also had an acute central necrosis of the liver at the time of the high SGOT activity. In no patient was there clinical, laboratory, or pathologic evidence of either hepatitis or active biliary tract disease. In none could other causes of elevated transaminase such as pulmonary infarction, skeletal muscle injury, brain injury, acute pancreatitis or drugs2 be incriminated.
In 11 patients the acute central necrosis of the liver was related to circulatory changes associated with an episode of acute myocardial infaretion. Necrosis of both the heart and the liver undoubtedly contributed to the elevated SGOT activity in this group, but the level of activity was considerably higher than that usually associated with an uncomplicated myocardial infaretion. In 6 patients, 4 of whom were autopsied, there was no evidence of infaretion of the heart and the very high levels of transaminase activity were probably related to liver necrosis aloiie.
Although certaint thatant increase in blood enizy-ie activity mneanms an incease in blood enizvym-e roiieiit.rationi. ' 1'Iie possibility that the chanoes in bloo(o enz-yme ac(tivity aIre Secondarv to (deianges in Inhibitors or activators c.,annot be r'uled out completely.
Thline (lata fronlt the (coiitiol Series, selected witlhoLt reg00a,r(l :f r the level of serumii enzymine ativityv, reinforce the oiserx aloniVIl that, in patienlts Awitih h.e,art (Ilsease, centrattl inecrosis of the liv er is a-Issoctiate.d ix it t elevate(l SGOT activilty 11(lldhyv) oteisioll. Vellou's hypertensioni alone was; niot associated with either increased SOT activity or acuite central nRecrosis of the: livrL iii the a,iseiicc of a fall in blood ])ressure. That piroloniged hyp}otensioni does not inivariably lead to hepatie ieerosis or el-evated SOOT is indieate(I by7 ease 17 of: the control series. We have too feW oliserva,tiolls inl jpatienits with prololllypj hiotell-Sion anld 110 right hiecairt failure to (Iraw firmili conc.lusion.s. Melhy (t al. have reported inoderate inc(reaNses ill SOOT()r aetivitv ill hypotensionl (dulle to (edlot-oxill,1.5 a conidit-ioni niot usuially c pOifll)amlie(I by hleart failure. 1'lasnia (Oa T activity inre a"'ses to ery lligh levels in (log's subjeeted to hemorrhagcic shock, and(l the liver is a major sourtc1e1 of tlis inerease.1" Aniv formn of periph eral Circulatory failure, if severe ellnoug, can probatbly pro(luce deficient liejpatic lperfllsion and hepati,e entral necrosis itit inIcreaUsed SGOT activity. lsolatctd instances of acute ecntral necrosis of tie liver:ii patients with high SOOT activity hative been previous'ly reported. 8' 1, is Publi,shed protocols indicate that m1tost patiets Wilth liaeute utiyocar(lial inifarctioii anid very high serum t ransaiunase levels havTe beell hypotenlsive. ( Tulle ptllogienesis of acm te eentral nic"rs-isof tile IiVer has been the subljeet of speculation sincee F. 1B. Mallory It lhas been shown that hepatic blood flow parallels the level of cardiac output in patienits with chronic heart failure and that the proportion of systemic flow diverted through the splanchuie bed remainis essen-tially constant. 35 ,3m Sinmilarly, in burni shock37 anid hlemorrlhagric shock38 hepatic blood flow deelines in proportion to the chaniges ini cardiac output. Cardiogen:ie shock :mlust also be accompanied by severe restriction of hepatic blood flow and very low oxyg,eni colntent in the hepatic veilns. ITepatic alnd mneseniterie oxygenation arie maintainied during shock by alnl increase in oxyoen extraction per unit of flow producing, a widened arteriovenious oxygen difference. 38 39 Under sueh circuinstances, those liver cells farthest fromrl the arterial and portal s-upply anid closest to the eentrtal veinis arc bathed in blood almost depleted of oxygen and other nutrients. At some critical point the vitality of the central cells is compromised and necrosis and loss of intracellular enzynles follow. If the circulatory reductioni is prololnged, cells more and mrlore distal to the central vein beginr to deteriorate, produeint, a picture of massive neero-Circulation, Volume XXI, May 1960 sis such as was encountered in W.T., D.O., W.D., and H.S.
In several cases with extensive central niecrosis, there was a bridging of necrotic cells from one central area to another ( fig. 4 ). If a patient should survive under such conditions, it is not difficult to visualize an extensive network of fibrous tissue eventually linking one hepatic lobule with another and resulting in a cardiac cirrhosis. The bridging between the central necrotic areas is completely in accord with Rappaport 's experimental evidence that the terminal branches of the hepatic inflow circulation arborize not only around the central vein but also in the border area between the lobules equidistant from the hepatic triads.40 These bridges of necrotic tissue, therefore, are further evidence of the role of circulatory changes in the pathogenesis of acute central necrosis.
Although all but 1 of the 17 patients with high SGOT activity had right heart failure, it is unlikely that venous hypertension alone produces either aeute central niecrosis or high levels of transaminase activity.8' 41 We have studied 8 patients with proved chronic constrictive pericarditis and severe elevation of venous pressure; SGOT activity was normal in all. Four patients in the control series died from heart failure with severe venous hypertension, and although all had varying degrees of atrophy and fibrosis around the central vein, none had either acute central necrosis or elevated SGOT activity prior to death. The chronic reduction in oxygen tension in the terminal branches of the hepatic veins associated with right heart failure42 may set the stage, however, for the rapid deterioration of the central cells after the development of cardiogenic shock and thus be synergistic with the acute reduction in hepatic blood flow.
The patients with high SGOT activity and myocardial infaretion had extensive myocardial necrosis by electrocardiographic criteria and at autopsy. In the experimental animal the level of SGOT activity correlates well with the size of the infarct.3-6 At least one of the experimental technics utilized to pro-Circulation, Volume XXI, MPa 1960 duce myocardial necrosis, however, is associated with proloniged cardiogenie s'-iock.3 4: It is possible that in som-le exl)erilnelts the high SGOT activity eflected both inyocardial and hepatic necrosis. A correlation between the size of the myocardial infaretioni ancd the level of SGOT activity has liot beeln established in man.
The association of high levels of tran1saminase activity and a poor progniosis il p)atiellts with cardiac disease has beei iiote'l by others particularly with invocardial inifaretioni.7. 8 Since this study has demonistrated that a highi level of SGOT activity in such patients implies hepatic necrosis, the correlationi between serum enzyme activity anid prognosis is probably not related strictly to the aiio-iiit of lnyocardial tissue damage, but rather to the ftunetional consequence of a giveni itnfaretioni. It is well known that myocardial infaretioni associated with shock carries a grave progOnosis.44 Inl terms of the function of the cardiovascular system, high levels of SGOT activity have the same clinical significance as shock and therefore signify a poor prognosis. Such high values, however, are more sensitive indieators of the level of hepatic perfusion than the blood pressure. This information mnay be useful at the bedside. Very high levels of SGOT in patients with cardiovascular disease should be an indication for vigorous attempts to treat the eirculatory inadequacy whether or nlot overt clinical shock be present. There is one final iiiplicatioii of this study that merits mention. Changes in blood enzyvme activity are widely utilized to eo-roborate a diagnosis of myocardial infaretion. Not infrequently if neither the elinical history nor the electrocardiogram is diagnostic, the interpretation of the changes in blood activity of SGOT or soime other non-organ-specific enzyme such as lactic dehydrogeinase nmay determine whether or not a patient is treated for acute myocardial infarction. If, as we ha e demonstrated, severe acute central necrosis of the liver produces striking elevation of serum enzyme activity, it is not unlikely that a minor degree of hepatic necrosis following acute circulatory changes may result in lesser elevations and indeed produce an activity curve mimicking that seen in myocardial infaretion. We have recently observed 2 elderly patients with complete heart block who had transaminase activity curves typical of myocardial infaretioni when their ventricular rate slowed and blood press)ure fell for several hours. In one the bradyeardia was secondary to high potassium and in the other to overdigitalization. In neither was there clinical or other laboratory evidence of acute myocardial infaretion. The implication is clear: SGOTactivity changes similar to those of myocardial infaretion may occur secondary to central necrosis of the liver unrelated to a myocardial infaret. Caution should be used in interpreting seruin transamiinase changes in patients with cardiac disease without diagnostic electrocardiographic or clinieal abnormalities. Determination of glutamic pyruvic transaminase levels may be helpful in such situations, sinee elevation of the serum activity of this enzyme appears largely to reflect liver necrosis and is unusual in uncomplicated myocardial infaretion.
Summary
A survey of all patients with very high serum glutamic oxalacetic transaminase activity encountered during a 30-month period at The New York Hospital revealed 17 patients with cardiac disease who had 1 or more serum giutamic oxalacetic transaminase (SG-OT) determinations exceeding 500 units.
None had clinical evidence of primary liver or gallbladder disease. Eleven were admitted with acute myocardial infarctioni, 6 with severe heart failure. All 17 developed hypotension or shock and all but 1 right heart failure prior to high SGOT activity.
Several patients had abnormalities of liver function when SGOT activity was very high. In 4 there was an excessive increase in prothrombin time following administration of anticoagulants.
In the 8 patients who came to autopsy there was histologic evidence of acute hepatic central necrosis. In 4 there was necrosis of both heart and liver, in 4 necrosis of liver alone.
Clinical and autopsy data from a control series of patients with heart disease selected without regard for the level of SGOT activity corroborate the association between hypotension, central necrosis of the liver, and increased SGOT activity. Inerease in venous pressure in the absence of hypotension was not associated with acute cenitral necrosis or elevated SGOT activity.
It-is concluded that very high SGOT activity (>500 units) in patients with heart disease is at least in part caused by acute hepatic central niecrosis secondary to a drop in cardiac output and reduced hepatic blood flow. Caution is urged in the interpretation of increased blood activity of intracellular enzymne systenis as evidence for myocardial necrosis. Acute circulatory changes may result in hepatic necrosis and increased blood enzyme activity without myocardial infaretion. dextero-cardiac ante le accusation del elevate activitate de TGOS.
Plure patientes habeva anormalitates del function hepatic quando le activitate de TGOS esseva multo elevate. In 4, un excessive augmento del tempore de prothrombina esseva notate post le administration de anticoagulantes.
In le 8 patientes presentate al necropsia, provas histologic de acute necrosis central del hepate esseva constatate. In 4 il habeva necrosis del hepate e del corde, in 4 solmente del hepate.
Datos clinic e necroptic ab un serie de controlo de patientes con morbo cardiac sed seligite sin reguardo al nivello del activitate de TGOS supporta le association inter hypotension, necrosis central del hepate, e augmento del activitate de TGOS. Augmento del tension venose in le absentia de hypotension non esseva associate con acute necrosis central o elevation del activitate de TGOS.
